Facioscapulohumeral Muscular Dystrophy
📧 Sign up to get email alerts when something new happens for Facioscapulohumeral Muscular Dystrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 1, Phase 2]
Phase 1/2 trial of AOC 1020 for facioscapulohumeral muscular dystrophy has completed enrollment; the update does not provide trial results.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy [Phase 1, Phase 2]
A first-in-human Phase 1/2 study of EPI-321 for facioscapulohumeral muscular dystrophy is currently recruiting, sponsored by Epicrispr Biote…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Amino Acids and Exercise in FSHD [NA]
A clinical trial is evaluating the effects of amino acids and exercise in facioscapulohumeral muscular dystrophy (FSHD); recruitment is ongo…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
A clinical trial update describes a project to identify and address barriers to drug development for Facioscapulohumeral Muscular Dystrophy.…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Pro-inflammatory Cytokines in Facioscapulohumeral Muscular Dystrophy (CYTOKINE-FSH) [NA]
Completed study evaluating pro-inflammatory cytokines in facioscapulohumeral muscular dystrophy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy [Phase 2]
This document provides an update on Hoffmann-La Roche's Phase 2 study of RO7204239 for facioscapulohumeral muscular dystrophy, currently act…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular Dystrophies [NA]
The document reports that a clinical trial studying walking analysis in adults with facioscapulohumeral muscular dystrophy is currently recr…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Quantitative Assessment of Orofacial Muscle Function in FSHD [NA]
This completed clinical trial from University of Mons evaluated quantitative measures of orofacial muscle function in individuals with facio…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD [Phase 2]
A Phase 2 study of apitegromab for facioscapulohumeral muscular dystrophy (FSHD) is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Clenbuterol to Target DUX4 in FSHD [Phase 1]
A Phase 1 clinical trial is ongoing to test clenbuterol as a therapy targeting DUX4 in facioscapulohumeral muscular dystrophy (FSHD) and is …
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
Clinical trial update for MOVE Peds, a pediatric study to validate motor outcome evaluations in facioscapulohumeral muscular dystrophy. The …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: BetterLife FSHD: A Patient-driven Health and Research Platform
The BetterLife FSHD trial platform, sponsored by the FSHD Society, is currently recruiting participants. It focuses on facioscapulohumeral m…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: New Clinical Outcome Measures to Remotely Evaluate Patients With FacioScapuloHumeral Muscular Dystrophy [NA]
This update describes the development of new remote clinical outcome measures for evaluating patients with facioscapulohumeral muscular dyst…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1 [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating ARO-DUX4 in adults and adolescents with facioscapulohumeral muscular dystrophy type 1. The st…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Dietary Protein Requirements in Adults With Facioscapulohumeral Muscular Dystrophy [NA]
Clinical trial evaluating dietary protein requirements in adults with facioscapulohumeral muscular dystrophy is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD [Phase 3]
A phase 3 clinical trial evaluating Del-brax (AOC-1020) for facioscapulohumeral muscular dystrophy is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings
A completed clinical trial reports ultrasound-based detection of early facial muscle changes in facioscapulohumeral muscular dystrophy, deta…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 1]
Phase 1 clinical trial update on ULSC for facioscapulohumeral muscular dystrophy, highlighting safety assessments and preliminary efficacy s…
-
CLINICAL_TRIALS other · 2025-12-03Clinical Trial Update: The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder [NA]
A clinical trial evaluating a muscle-mimicking fabric-type shoulder orthosis to improve upper-limb movements in patients with neuromuscular …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study [NA]
A prospective 24-month MRI study of facioscapulohumeral muscular dystrophy (FSHD) in France, sponsored by Centre Hospitalier Universitaire d…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Biomarker Development for Muscular Dystrophies
Massachusetts General Hospital sponsors a clinical trial update focused on developing biomarkers for muscular dystrophy. The study is curren…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) [Phase 3]
Phase 3 trial update for losmapimod in facioscapulohumeral muscular dystrophy (FSHD) indicates the study was terminated and results have bee…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
A registry study update listing RECRUITING status for Myotonic Dystrophy type 1, Myotonic Dystrophy type 2, and Facioscapulohumeral muscular…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE) [Phase 2]
Phase 2 open-label extension study of losmapimod for facioscapulohumeral muscular dystrophy reports efficacy and safety results; the trial i…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: ADVANCED FSHD-COM: New Clinical Outcome Measures to Evaluate Non-ambulant FSHD Patients, a Pilot Study [NA]
This clinical trial update describes a pilot study to develop and evaluate new clinical outcome measures for non-ambulant patients with faci…